Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease

The pathogenesis of Rheumatoid Arthritis (RA) is not fully understood, probably influenced by genetic and environmental factors. Interstitial Lung Disease (ILD) is an extra-articular manifestation of RA, which contributes significantly to morbidity and mortality. The identification of anti-HLA antib...

Full description

Bibliographic Details
Main Authors: Alma D. Del Angel-Pablo, Ivette Buendía-Roldán, Mayra Mejía, Gloria Pérez-Rubio, Karol J. Nava-Quiroz, Jorge Rojas-Serrano, Ramcés Falfán-Valencia
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/3/691
_version_ 1797717009792761856
author Alma D. Del Angel-Pablo
Ivette Buendía-Roldán
Mayra Mejía
Gloria Pérez-Rubio
Karol J. Nava-Quiroz
Jorge Rojas-Serrano
Ramcés Falfán-Valencia
author_facet Alma D. Del Angel-Pablo
Ivette Buendía-Roldán
Mayra Mejía
Gloria Pérez-Rubio
Karol J. Nava-Quiroz
Jorge Rojas-Serrano
Ramcés Falfán-Valencia
author_sort Alma D. Del Angel-Pablo
collection DOAJ
description The pathogenesis of Rheumatoid Arthritis (RA) is not fully understood, probably influenced by genetic and environmental factors. Interstitial Lung Disease (ILD) is an extra-articular manifestation of RA, which contributes significantly to morbidity and mortality. The identification of anti-HLA antibodies has been useful in the transplantation field; however, its contribution to autoimmune diseases as RA has not been fully studied. We aimed to determine the presence of anti-HLA antibodies in RA patients with and without ILD and its possible association with clinical and biochemical markers. One-hundred and forty-seven RA patients, of which 65 had ILD (RA-ILD group), were included. Sera samples for Anti-HLA Class II LABScreen panel-reactive antibodies (PRA) were analyzed. In both groups, women predominated, and lung function was worse in patients with ILD. The anti-CCP+ (UI/mL) was higher in the RA group in comparison to RA-ILD (<i>p</i> &lt; 0.001). Expositional risk factors (tobacco smoking and biomass-burning smoke) were higher in RA-ILD patients. PRA+ was identified in ~25% RA-ILD patients, while ~29% in the RA group. The CRP levels have a positive correlation with the percentage of reactivity (%PRA, <i>p</i> = 0.02, r<sup>2</sup> = 0.60) in the RA-ILD group. In conclusion, anti-HLA antibodies correlate with C-reactive protein levels in RA patients with ILD.
first_indexed 2024-03-12T08:29:58Z
format Article
id doaj.art-9c5d8058782d4a85b6b858bbc56233dc
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-12T08:29:58Z
publishDate 2020-03-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-9c5d8058782d4a85b6b858bbc56233dc2023-09-02T17:50:10ZengMDPI AGCells2073-44092020-03-019369110.3390/cells9030691cells9030691Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung DiseaseAlma D. Del Angel-Pablo0Ivette Buendía-Roldán1Mayra Mejía2Gloria Pérez-Rubio3Karol J. Nava-Quiroz4Jorge Rojas-Serrano5Ramcés Falfán-Valencia6HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, 14080 Mexico City, MexicoTranslational Research Laboratory on Aging and Pulmonary Fibrosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, 14080 Mexico City, MexicoInterstitial Lung Disease and Rheumatology Unit, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, 14080 Mexico City, MexicoHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, 14080 Mexico City, MexicoHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, 14080 Mexico City, MexicoInterstitial Lung Disease and Rheumatology Unit, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, 14080 Mexico City, MexicoHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, 14080 Mexico City, MexicoThe pathogenesis of Rheumatoid Arthritis (RA) is not fully understood, probably influenced by genetic and environmental factors. Interstitial Lung Disease (ILD) is an extra-articular manifestation of RA, which contributes significantly to morbidity and mortality. The identification of anti-HLA antibodies has been useful in the transplantation field; however, its contribution to autoimmune diseases as RA has not been fully studied. We aimed to determine the presence of anti-HLA antibodies in RA patients with and without ILD and its possible association with clinical and biochemical markers. One-hundred and forty-seven RA patients, of which 65 had ILD (RA-ILD group), were included. Sera samples for Anti-HLA Class II LABScreen panel-reactive antibodies (PRA) were analyzed. In both groups, women predominated, and lung function was worse in patients with ILD. The anti-CCP+ (UI/mL) was higher in the RA group in comparison to RA-ILD (<i>p</i> &lt; 0.001). Expositional risk factors (tobacco smoking and biomass-burning smoke) were higher in RA-ILD patients. PRA+ was identified in ~25% RA-ILD patients, while ~29% in the RA group. The CRP levels have a positive correlation with the percentage of reactivity (%PRA, <i>p</i> = 0.02, r<sup>2</sup> = 0.60) in the RA-ILD group. In conclusion, anti-HLA antibodies correlate with C-reactive protein levels in RA patients with ILD.https://www.mdpi.com/2073-4409/9/3/691anti-hla antibodiespanel-reactive antibodiesc-reactive proteinrheumatoid arthritisinterstitial lung diseaseanti-ccp+pra
spellingShingle Alma D. Del Angel-Pablo
Ivette Buendía-Roldán
Mayra Mejía
Gloria Pérez-Rubio
Karol J. Nava-Quiroz
Jorge Rojas-Serrano
Ramcés Falfán-Valencia
Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease
Cells
anti-hla antibodies
panel-reactive antibodies
c-reactive protein
rheumatoid arthritis
interstitial lung disease
anti-ccp+
pra
title Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease
title_full Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease
title_fullStr Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease
title_full_unstemmed Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease
title_short Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease
title_sort anti hla class ii antibodies correlate with c reactive protein levels in patients with rheumatoid arthritis associated with interstitial lung disease
topic anti-hla antibodies
panel-reactive antibodies
c-reactive protein
rheumatoid arthritis
interstitial lung disease
anti-ccp+
pra
url https://www.mdpi.com/2073-4409/9/3/691
work_keys_str_mv AT almaddelangelpablo antihlaclassiiantibodiescorrelatewithcreactiveproteinlevelsinpatientswithrheumatoidarthritisassociatedwithinterstitiallungdisease
AT ivettebuendiaroldan antihlaclassiiantibodiescorrelatewithcreactiveproteinlevelsinpatientswithrheumatoidarthritisassociatedwithinterstitiallungdisease
AT mayramejia antihlaclassiiantibodiescorrelatewithcreactiveproteinlevelsinpatientswithrheumatoidarthritisassociatedwithinterstitiallungdisease
AT gloriaperezrubio antihlaclassiiantibodiescorrelatewithcreactiveproteinlevelsinpatientswithrheumatoidarthritisassociatedwithinterstitiallungdisease
AT karoljnavaquiroz antihlaclassiiantibodiescorrelatewithcreactiveproteinlevelsinpatientswithrheumatoidarthritisassociatedwithinterstitiallungdisease
AT jorgerojasserrano antihlaclassiiantibodiescorrelatewithcreactiveproteinlevelsinpatientswithrheumatoidarthritisassociatedwithinterstitiallungdisease
AT ramcesfalfanvalencia antihlaclassiiantibodiescorrelatewithcreactiveproteinlevelsinpatientswithrheumatoidarthritisassociatedwithinterstitiallungdisease